1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 34 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysisCraven, A.; Hawley, C.; McDonald, S.; Rosman, J.; Brown, F.; Johnson, D.
2017Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysisHtay, H.; Cho, Y.; Pascoe, E.; Darssan, D.; Nadeau-Fredette, A.; Hawley, C.; Clayton, P.; Borlace, M.; Badve, S.; Sud, K.; Boudville, N.; McDonald, S.; Johnson, D.
2021Associations between diabetes and sex with peritoneal dialysis technique and patient survival: Results from the Australia and New Zealand Dialysis and Transplant Registry cohort studyChen, J.H.; Johnson, D.W.; Wong, G.; Boudville, N.; Borlace, M.; Walker, R.; Hawley, C.; McDonald, S.; Lim, W.H.
2020Novel trial strategies to enhance the relevance, efficiency, effectiveness and impact of nephrology researchDansie, K.; Viecelli, A.K.; Pascoe, E.M.; Johnson, D.W.; McDonald, S.; Clayton, P.; Hawley, C.
2015Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialBadve, S.; Zhang, L.; Coombes, J.; Pascoe, E.; Cass, A.; Clarke, P.; Ferrari, P.; McDonald, S.; Morrish, A.; Pedagogos, E.; Perkovic, V.; Reidlinger, D.; Scaria, A.; Walker, R.; Vergara, L.; Hawley, C.; Johnson, D.
2016The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: sub-study of the HERO trialZhang, L.; Coombes, J.; Pascoe, E.; Badve, S.; Dalziel, K.; Cass, A.; Clarke, P.; Ferrari, P.; McDonald, S.; Morrish, A.; Pedagogos, E.; Perkovic, V.; Reidlinger, D.; Scaria, A.; Walker, R.; Vergara, L.; Hawley, C.; Johnson, D.
2015End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-outcomes in 66 consecutive ANZDATA registry casesMallett, A.; Tang, W.; Hart, G.; McDonald, S.; Hawley, C.; Badve, S.; Boudville, N.; Brown, F.; Campbell, S.; Clayton, P.; Johnson, D.
2022Representativeness of the PDOPPS cohort compared to the Australian PD populationEthier, I.; Boudville, N.; McDonald, S.; Brown, F.; Kerr, P.G.; Walker, R.; Holt, S.G.; Badve, S.V.; Cho, Y.; Hawley, C.; Robison, L.; Reidlinger, D.; Milanzi, E.; Bieber, B.; McCullough, K.; Johnson, D.W.
2013Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomesCho, Y.; Badve, S.; Hawley, C.; McDonald, S.; Brown, F.; Boudville, N.; Bannister, K.; Clayton, P.; Johnson, D.
2021Socioeconomic disparity, access to care and patient relevant outcomes after kidney allograft failure.Wong, Y.H.S.; Wong, G.; Johnson, D.W.; McDonald, S.; Clayton, P.; Boudville, N.; Viecelli, A.K.; Lok, C.; Pilmore, H.; Hawley, C.; Roberts, M.A.; Walker, R.; Ooi, E.; Polkinghorne, K.R.; Lim, W.H.

Discover